.png)
The Stress and Risks of PBM Audits
For pharmacies, few events are as stressful, or as disruptive, as a PBM audit. These audits often result in findings that are exaggerated, misleading, or simply inaccurate. Even minor inventory discrepancies or routine record-keeping errors can trigger steep recoupment demands and, in some cases, lead to network termination. The important point to remember is that pharmacies do not have to accept adverse audit findings at face value. Every audit finding can be appealed, and there are effective strategies to challenge improper results and significantly reduce or eliminate clawbacks based on inaccurate audit findings.
Reviewing and Rebutting Audit Findings
The appeal process begins with a careful review of the audit and/or discrepancy report. PBM auditors frequently cite technical issues, such as missing inventory records, missing patient signatures, minor inconsistencies in prescription records, or gaps in copayment documentation, as grounds for full recoupment. In many situations, these alleged deficiencies can be rebutted by submitting supplemental records, clarifying documentation, or obtaining patient attestations. A thorough, line-by-line analysis of the discrepancy report is essential to uncovering errors and mounting a strong defense.
Protecting Contractual Rights During the Appeal
Pharmacies must also be mindful of their contractual rights. PBM provider manuals set strict timelines and procedures for disputing audit results. Missing a deadline or failing to submit the required information can make it nearly impossible to overturn an adverse finding. Responding quickly, completely, and in compliance with contractual requirements is critical to protecting the pharmacy’s position and avoiding unwarranted repayment obligations.
Providing Context to Alleged Discrepancies
Moreover, providing context to certain alleged discrepancies can further strengthen a pharmacy’s defense. For example, what may appear to be a suspicious pattern, such as a high number of claim reversals, can often be explained by inventory shortages requiring reversals or by patient-driven requests, both of which are factors entirely outside the pharmacy’s control. Explaining these circumstances and supporting them with appropriate documentation can help dismantle PBM assumptions and reduce the likelihood of unfair recoupment.
The Value of Experienced Legal Counsel
Because the financial and operational stakes are so high, pharmacies benefit from working with an experienced healthcare attorney who has specific knowledge of PBM audits and appeals. A skilled PBM audit attorney can identify weaknesses in the audit findings, ensure contractual rights are preserved, and prepare formal appeals backed by legal and factual analysis. When necessary, PBM defense attorneys can also escalate matters to prevent unjust clawbacks and protect network participation.
How Health Law Alliance Can Help
At Health Law Alliance, we represent pharmacies nationwide in challenging PBM audit findings and defending against network terminations. Our attorneys understand the tactics PBMs use during audits and know how to craft effective appeals that protect pharmacies from unfair financial and operational consequences. Whether you are reviewing a recent audit report, preparing an appeal, or facing threats of network termination, contact us today to learn how we can help you challenge PBM audit findings and/or network termination notices before they cause lasting harm to your pharmacy.
MORE ARTICLES BY CATEGORY
The 2025 Healthcare Fraud Takedown Is a Warning Shot for Wound Care Providers
Wound care is now an enforcement priority. The 2025 fraud takedown targets skin substitute billing, graft utilization, and Medicare compliance.
Read More >>FDA and Novo’s Uncharted Waters to Exert Pressure on Hims & Hers and GLP-1 Compounders
Novo’s lawsuit against Hims & Hers, coupled with FDA’s referral to the DOJ, marks a direct escalation against 503A compounded semaglutide. If your pharmacy dispenses, compounds, or markets GLP-1 therapies, this is not a headline, it is a regulatory turning point.
Read More >>What Wells Pharma v. Zyla Life Sciences Means for Compounding Pharmacies and Outsourcing Facilities
A pending Supreme Court case could reshape how compounding pharmacies face litigation under state unfair competition laws tied to FDA approval standards.
Read More >>Health Law Alliance Welcomes Compounding Expert Pharmacist-Attorney Dr. Martha Rumore as Of Counsel
Health Law Alliance adds powerhouse Pharmacist/Attorney Dr. Martha Rumore to their team of boutique healthcare attorneys.
Read More >>







